<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00348907</url>
  </required_header>
  <id_info>
    <org_study_id>DCIC 05 45</org_study_id>
    <nct_id>NCT00348907</nct_id>
  </id_info>
  <brief_title>EVENT: Hydrotherapy and Deep Venous Thrombosis</brief_title>
  <official_title>Evaluation of the Efficacy of the Thermal Cure in the Prevention of the Post-Thrombotic Syndrome After a Deep Venous Thrombosis of Lower Limbs.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Association Francaise pour la Recherche Thermale</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Association Francaise pour la Recherche Thermale</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to demonstrate that hydrotherapy in a specific place can
      reduce the risk of post-thrombotic syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Venous thrombo-embolic disease (VTED) is a frequent pathology. The incidence is about 5 to 20
      cases for 10000 persons each year, in a general population. The immediate risk is the
      pulmonary embolism potentially fatal. So, it justifies all the works in clinical research
      during the last years. Those studies allow many progresses, diagnostic and therapeutic, for
      the immediate undertaking of the patients. Despite that, VTED is a major problem of public
      health and the diminution of the mortality lied to VTED is one of the objectives of the
      French law relative to the politics of Public Health (August 2004). At more long-term, the
      post-thrombotic syndrome lead to an incapacitating pathology, which requires many cares. The
      frequency of the post-thrombotic syndrome is evaluated between 25 and 60% at middle-term (1
      or 2 years). It depends of the studies and of the clinical primary end-points or vascular
      explorations. Rehabilitation has never been validated in this indication by studies with a
      correct methodology.

      Deep venous thrombosis (not in acute phase) is recognized as an indication for about 10 spa
      in France. But the specific or global benefit of this water cure is not clearly and
      scientifically proved. The importance of the venous pump of the calf and of the hydrostatic
      pressure in the physiopathology of the post-thrombotic syndrome make natural the use of
      balneotherapy for the prevention of this pathology for patients with severe deep venous
      thrombosis of lower limbs (proximal and obstruent). The venous thermal techniques have
      well-defined physiopathological targets. The haemodynamic and microcirculatory effects of
      some of them have been proved. The high degree of satisfaction of the patients that benefit
      from phlebological water cure every year in France indirectly shows the benefits that they
      feel. In those indications, prevention of the post-thrombotic syndrome is one of the
      well-recognize by the medical profession. For all that, there was not really validation of
      this indication with an acceptable methodology for the canons of the modern medicine. That is
      the reason why we undertake this randomized, single-blind controlled study with for main
      objective to demonstrate that hydrotherapy in a specific place can reduce the risk of
      post-thrombotic syndrome.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    decision to stop the study because of enrollment difficulties.
  </why_stopped>
  <start_date>July 2006</start_date>
  <completion_date type="Actual">December 2006</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence at 1 year of a severe post-thrombotic syndrome clinically defined.</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-thrombotic syndrome at 2 years;</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life: CIVIQ Scale;</measure>
    <time_frame>inclusion, 1, 2 years before and after thermal cure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensity of the symptoms of venous insufficiency auto evaluation by patient</measure>
    <time_frame>monthly</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Deep venous reflux (evaluated by echo-doppler);</measure>
    <time_frame>inclusion, 1 and 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistence of a residual thrombus (echo-doppler);</measure>
    <time_frame>inclusion, 1 and 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between clinical evolution and echo-doppler evolution of the venous after-effects;</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Benefit of a late cure at 2 years.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Pain</condition>
  <condition>Deep Venous Thrombosis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>immediate thermal cure (1st year)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>late thermal cure (2 years)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>thermal cure</intervention_name>
    <description>thermal cure of 18 days including movement in swimming pool, mud-bath, shower, massage and thermal steam</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>late thermal cure</intervention_name>
    <description>thermal cure of 18 days including movement in swimming pool, mud-bath, shower, massage and thermal steam at 2 years</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  both sexes;

          -  18 years old and more;

          -  clinical indication of thermal cure (first phase of deep venous thrombosis
             authenticated by unilateral venous echo-doppler

          -  curative anticoagulant treatment more than 3 month;

          -  oedema and/or spontaneous pain with functional discomfort;

          -  available for a thermal cure during 18 days and a follow-up period of 36 month;

          -  voluntary to participate to the study, informed consent form signed after appropriate
             information;

          -  affiliation to the social security system or equivalent;

          -  no previous participation to a thermal cure (in the indication of phlebology)

        Exclusion Criteria:

          -  isolate distal thrombosis;

          -  asymptomatic thrombosis;

          -  cutaneous ulcer of lower limb;

          -  refusal to consent;

          -  refusal to benefit of thermal cure;

          -  contra-indication to hydrotherapy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fran√ßois POIRAULT, Dr</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Etablissement thermal</name>
      <address>
        <city>Argeles-Gazost</city>
        <zip>65400</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Etablissement thermal</name>
      <address>
        <city>Bagnoles de l'orne</city>
        <zip>61140</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Etablissement thermal</name>
      <address>
        <city>Barbotan-les-thermes</city>
        <zip>32150</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>L'avenue</name>
      <address>
        <city>DAX</city>
        <zip>40100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sarrailh</name>
      <address>
        <city>Dax</city>
        <zip>40100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Le Splendid</name>
      <address>
        <city>Dax</city>
        <zip>40101</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Les thermes</name>
      <address>
        <city>Dax</city>
        <zip>40101</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Le miradour</name>
      <address>
        <city>Dax</city>
        <zip>40103</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Les ar√®nes</name>
      <address>
        <city>DAX</city>
        <zip>40103</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>B√©rot</name>
      <address>
        <city>Dax</city>
        <zip>40104</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Les √©cureuils</name>
      <address>
        <city>Dax</city>
        <zip>40104</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dax thermal</name>
      <address>
        <city>Dax</city>
        <zip>40105</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Foch</name>
      <address>
        <city>Dax</city>
        <zip>40105</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Borda</name>
      <address>
        <city>Dax</city>
        <zip>40106</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint-Pierre</name>
      <address>
        <city>Dax</city>
        <zip>40106</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Le Grand H√¥tel</name>
      <address>
        <city>Dax</city>
        <zip>40108</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Le Regina</name>
      <address>
        <city>Dax</city>
        <zip>40108</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Etablissement thermal</name>
      <address>
        <city>Evian-les-bains</city>
        <zip>23110</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Domaine d'heurteboise</name>
      <address>
        <city>Jonzac</city>
        <zip>17503</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Etablissement thermal</name>
      <address>
        <city>La L√©ch√®re</city>
        <zip>73260</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Etablissement thermal</name>
      <address>
        <city>Luxeuil-les-bains</city>
        <zip>70300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Etablissement thermal</name>
      <address>
        <city>Luz-saint-sauveur</city>
        <zip>65120</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Etablissement thermal</name>
      <address>
        <city>Rochefort-sur-mer</city>
        <zip>17300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Caliceo</name>
      <address>
        <city>Saint-Paul-les-Dax</city>
        <zip>40990</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christus</name>
      <address>
        <city>Saint-Paul-les-Dax</city>
        <zip>40990</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ch√™nes</name>
      <address>
        <city>Saint-Paul-les-Dax</city>
        <zip>40990</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Etablissmeent thermal</name>
      <address>
        <city>Saubusse-les-bains</city>
        <zip>40180</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M, Cattelan AM, Polistena P, Bernardi E, Prins MH. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996 Jul 1;125(1):1-7.</citation>
    <PMID>8644983</PMID>
  </reference>
  <reference>
    <citation>Kahn SR, Kearon C, Julian JA, Mackinnon B, Kovacs MJ, Wells P, Crowther MA, Anderson DR, Van Nguyen P, Demers C, Solymoss S, Kassis J, Geerts W, Rodger M, Hambleton J, Ginsberg JS; Extended Low-intensity Anticoagulation for Thrombo-embolism (ELATE) Investigators. Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis. J Thromb Haemost. 2005 Apr;3(4):718-23. Epub 2005 Feb 23.</citation>
    <PMID>15733061</PMID>
  </reference>
  <reference>
    <citation>Labropoulos N, Leon LR Jr. Duplex evaluation of venous insufficiency. Semin Vasc Surg. 2005 Mar;18(1):5-9. Review.</citation>
    <PMID>15791546</PMID>
  </reference>
  <reference>
    <citation>Asbeutah AM, Riha AZ, Cameron JD, McGrath BP. Reproducibility of duplex ultrasonography and air plethysmography used for the evaluation of chronic venous insufficiency. J Ultrasound Med. 2005 Apr;24(4):475-82.</citation>
    <PMID>15784766</PMID>
  </reference>
  <reference>
    <citation>Launois R, Reboul-Marty J, Henry B. Construction and validation of a quality of life questionnaire in chronic lower limb venous insufficiency (CIVIQ). Qual Life Res. 1996 Dec;5(6):539-54.</citation>
    <PMID>8993100</PMID>
  </reference>
  <verification_date>October 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 4, 2006</study_first_submitted>
  <study_first_submitted_qc>July 5, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 6, 2006</study_first_posted>
  <last_update_submitted>October 31, 2007</last_update_submitted>
  <last_update_submitted_qc>October 31, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 1, 2007</last_update_posted>
  <keyword>doppler</keyword>
  <keyword>CIVIQ quality of life</keyword>
  <keyword>Hydrotherapy</keyword>
  <keyword>anticoagulants</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Venous Thrombosis</mesh_term>
    <mesh_term>Postthrombotic Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

